We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Michele Trott, PhD

Michele Trott, PhD

Michele Trott (nee Wilson) is a New Zealand-based science writer who pursues freelance writing projects alongside her in-house role as a scientific content writer at Izon Science. After completing her PhD (Endocrinology) at Lincoln University (NZ), Michele began pursuing her science writing career with Technology Networks in the UK. There, she spent 12 months covering a maternity leave role as a science editor, and managed the cell science, biopharma and diagnostics communities. Upon her arrival back in NZ, Michele established “Choice Science Writing” and became a full-time freelance science writer, working with life science marketing agencies, biotech companies – and of course, Technology Networks – to produce engaging articles and blog posts. In April 2021, she took up the opportunity to join the team at Izon Science, a company that enables the precise separation and analysis of extracellular vesicles and other nanoparticles.


Got a question for Michele Trott, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 111
Colorectal Cancer Blood Test Driven by Immuno-transcriptomics content piece image
Industry Insight

Colorectal Cancer Blood Test Driven by Immuno-transcriptomics

By studying gene expression modifications induced by the immune response, Novigenix has developed a blood test for colorectal cancer. This Q&A with Jan Groen, CEO, provides insights on the test, and on the field of study that could revolutionize cancer diagnosis.
World’s First Reported Spontaneous Clearance of HIV, Without Treatment content piece image
News

World’s First Reported Spontaneous Clearance of HIV, Without Treatment

In 1981, a patient from Sydney was transfused with a weakened form of HIV-1 when he received a blood transfusion following a motorbike accident. After controlling his infection for more than 30 years, he appears to have cleared his infection altogether – without therapy.
Anti-influenza Agents Inspired by Immunotherapy content piece image
Industry Insight

Anti-influenza Agents Inspired by Immunotherapy

Given the urgent need for compounds that can effectively prevent and treat influenza, San Diego-based Cidara Therapeutics are working to develop antiviral conjugates. We spoke to Les Tari, Senior VP of Research, to find out about their unique approach and lead candidate.
Why Should Antibodies Be Manufactured Recombinantly? content piece image
Industry Insight

Why Should Antibodies Be Manufactured Recombinantly?

Given that bad antibodies are likely to blame for a significant proportion of the reproducibility crisis in science, any efforts to reduce batch-to-batch variability are more than welcome. One company with a plan to help in this area is “Absolute Antibody”, who believe that recombinant antibodies are the way forward. To learn more about making antibodies with recombinant technology, we spoke to Ian Wilkinson, PhD, Chief Scientific Officer.
Cell Migration: Clinical Relevance, Unique Movement Patterns and Driving Technologies content piece image
Article

Cell Migration: Clinical Relevance, Unique Movement Patterns and Driving Technologies

Cells like to move it, move it! Understanding the mechanisms behind cell migration represents an important piece to the puzzle of many fundamental biological processes and pathologies. This article delves into textbook models of cell migration, recent insights on movement patterns, and highlights the technology driving cell migration research forward.
When Art Meets Science and Food Coloring, Bioprinting Prospers content piece image
News

When Art Meets Science and Food Coloring, Bioprinting Prospers

A new open-source method for bioprinting represents a breakthrough for the field of regenerative medicine, and its success stems from a special ingredient: food dye.
Entering the Antibody Lottery: Tips for Avoiding Dubious Sources content piece image
Industry Insight

Entering the Antibody Lottery: Tips for Avoiding Dubious Sources

Having reliable antibodies can make or break your assay. However, sourcing the right antibody for the job can sometimes feel like you’re entering the lottery: there are so many on the market, and often they just don’t live up to what was promised. To learn more about antibody validation and its importance, we got in touch with Anthony Couvillon, PhD, Scientific Marketing Project Manager at Cell Signaling Technology.
Flow Cytometry in the Clinic content piece image
Industry Insight

Flow Cytometry in the Clinic

Flow cytometry is a technique used to count and analyze the size, shape and properties of individual cells. Not just a valuable research tool, flow cytometry is also finding its stride in several clinical areas. Following BD Biosciences’ launch of a new sample preparation instrument, we spoke to Stephen Gunstream, VP and general manager, to get his insights on the role of flow cytometry in the clinic.
Meal Timing Can Make or Break Your Cells' Circadian Rhythm content piece image
News

Meal Timing Can Make or Break Your Cells' Circadian Rhythm

It is well known that exposure to daylight keeps our body clock in check. But what impact does meal timing have? A new study published in Cell helps answer this question and provides new insights on how cells keep a circadian rhythm. The study also has important implications for shift workers and travelers wanting to avoid jet lag.
How To Prevent Cell Culture Contamination content piece image
Infographic

How To Prevent Cell Culture Contamination

Cells in culture are vulnerable to contaminants derived from a large range of potential sources. Download this infographic to arm yourself with knowledge about different types of contaminants, and find out how to avoid contamination of your cultures.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter